An NHS England study in children and young people has showed improvements in glycaemic control, time in range, frequency of hypoglycaemia, hypoglycaemia fear and quality of sleep for children and young people when using hybrid closed-loop (HCL) systems for six months. Hypoglycaemia fear and quality of sleep were also improved for their parents and carers.
HCL systems are characterised by integrating continuous glucose monitoring (CGM) with insulin pumps that automate insulin delivery via specific algorithms and user-initiated insulin delivery. The three HCL systems used in the study of 251 children and young people were the Tandem Control-IQ AP system, the Medtronic MiniMed 780G and the CamAPS FX.
In addition, the NHS is currently reporting that approximately eight in 10 people now have access to continuous glucose monitoring devices, with nearly two-thirds of local NHS areas already offering the devices to patients, and the NHS is aiming for all areas to be offering both continuous glucose monitors and flash monitors in 2023.